Ignite Creation Date:
2024-05-06 @ 1:31 PM
Last Modification Date:
2024-10-26 @ 1:15 PM
Study NCT ID:
NCT04044430
Status:
TERMINATED
Last Update Posted:
2023-01-09
First Post:
2019-08-01
Brief Title:
Encorafenib Binimetinib and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IVC Rectal Cancer |
| Metastatic Colon Adenocarcinoma |
| Metastatic Colorectal Adenocarcinoma |
| Metastatic Microsatellite Stable Colorectal Carcinoma |
| Metastatic Rectal Adenocarcinoma |
| Stage III Colon Cancer |
| Stage III Colorectal Cancer |
| Stage III Rectal Cancer |
| Stage IIIA Colon Cancer |
| Stage IIIA Colorectal Cancer |
| Stage IIIA Rectal Cancer |
| Stage IIIB Colon Cancer |
| Stage IIIB Colorectal Cancer |
| Stage IIIB Rectal Cancer |
| Stage IIIC Colon Cancer |
| Stage IIIC Colorectal Cancer |
| Stage IIIC Rectal Cancer |
| Stage IV Colon Cancer |
| Stage IV Colorectal Cancer |
| Stage IV Rectal Cancer |
| Stage IVA Colon Cancer |
| Stage IVA Colorectal Cancer |
| Stage IVA Rectal Cancer |
| Stage IVB Colon Cancer |
| Stage IVB Colorectal Cancer |
| Stage IVB Rectal Cancer |
| Stage IVC Colon Cancer |
| Stage IVC Colorectal Cancer |